CRISPR Therapeutics AG (CRSP)
46.75
-0.20
(-0.43%)
USD |
NASDAQ |
Mar 20, 11:12
CRISPR Therapeutics EPS Diluted (Quarterly) : -1.371 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Beam Therapeutics, Inc. | 2.328 |
| Novartis AG | 1.249 |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -130.61M |
| Revenue (Quarterly) | 0.864M |
| Total Expenses (Quarterly) | 131.48M |
| Enterprise Value | 2.730B |
| Gross Profit Margin (Quarterly) | -6.77K% |
| Profit Margin (Quarterly) | -15.12K% |
| Earnings Yield | -13.93% |
| Normalized Earnings Yield | -12.46 |